[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.172.174. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 4, 2006

Apolipoprotein E and Progression of Chronic Kidney Disease—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;295(1):35-36. doi:10.1001/jama.295.1.35-b

In Reply: Dr Kida suggests that the use of ACE inhibitors or ARBs may confound the association between APOE genotype and chronic kidney disease progression. Use of antihypertensive medication had been adjusted for in our multivariate Cox models and did not modify the association between APOE and chronic kidney disease progression, which is the expected result given that antihypertensive medication use should not be associated with APOE genotype.

First Page Preview View Large
First page PDF preview
First page PDF preview
×